Net Cash Provided by (Used in) Operating Activities |
110M |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-44.9M |
USD |
-112% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-235M |
USD |
-115% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
120M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
50.7M |
shares |
+0.17% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-170M |
USD |
-194% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
158M |
USD |
-56% |
Mar 31, 2024 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
37.8M |
USD |
+38.5% |
Mar 31, 2024 |
Q1 2024 |
Payments to Acquire Property, Plant, and Equipment |
260M |
USD |
+120% |
Mar 31, 2024 |
Q1 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
249M |
USD |
-15.6% |
Mar 31, 2024 |
Q1 2024 |
Deferred Income Tax Expense (Benefit) |
-21.7M |
USD |
-126% |
Dec 31, 2023 |
Q4 2023 |
Deferred Federal Income Tax Expense (Benefit) |
-18.4M |
USD |
-34.5% |
Dec 31, 2023 |
Q4 2023 |
Current Income Tax Expense (Benefit) |
-7.62M |
USD |
-121% |
Dec 31, 2023 |
Q4 2023 |
Unrecognized Tax Benefits |
0 |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Current State and Local Tax Expense (Benefit) |
5.63M |
USD |
+2.92% |
Dec 31, 2023 |
Q4 2023 |
Current Federal Tax Expense (Benefit) |
-13.3M |
USD |
-142% |
Dec 31, 2023 |
Q4 2023 |
Depreciation, Depletion and Amortization |
55.2M |
USD |
+18.9% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
328M |
USD |
+12.6% |
Dec 31, 2023 |
Q4 2023 |
Deferred State and Local Income Tax Expense (Benefit) |
-3.27M |
USD |
-180% |
Dec 31, 2023 |
Q4 2023 |
Interest Expense |
116M |
USD |
+30.3% |
Dec 31, 2023 |
Q4 2023 |